Matrix deposition of tryptophan-containing allelic variants of type IX collagen in developing human cartilage

Matrix Biology

Volumn 22, Issue 2, 2003, Pages 123-129

  Matsui, Yoshito ^a   Wu, Jiann Jiu ^a   Weis, Mary Ann ^a   Pietka, Terri ^a   Eyre, David R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

COL9A2; COL9A3; Extracellular matrix; Intervertebral disc; Lumbar disc disease; Polymorphism

Indexed keywords

COLLAGEN TYPE 9; TRYPTOPHAN;

ALLELISM; ARTICLE; CARTILAGE; CONTROLLED STUDY; CROSS LINKING; EMBRYO; EXTRACELLULAR MATRIX; FETUS; GENOTYPE; HUMAN; HUMAN TISSUE; PEPTIDE MAPPING; PHYSICAL DEVELOPMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING; WESTERN BLOTTING;

ALLELES; AMINO ACID SEQUENCE; BASE SEQUENCE; CARTILAGE; COLLAGEN TYPE IX; EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; EXTRACELLULAR MATRIX; GENE FREQUENCY; HUMANS; RNA, MESSENGER; TRYPTOPHAN; VARIATION (GENETICS);

EID: 0038024593     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(02)00102-6     Document Type: Article

References (27)

1. Annunen S., Paassilta P., Lohiniva J., et al. An allele of COL9A2 associated with intervertebral disc disease. Science. 285:1999;409-412.
2. Bönnemann C.G., Cox G.F., Shapiro F., et al. A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy. Proc. Natl. Acad. Sci. USA. 97:2000;1212-1217.
3. Czarny-Ratajczak M., Lohiniva J., Rogala P., et al. A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity. Am. J. Hum. Genet. 69:2001;969-980.
4. Diab M., Wu J.-J., Eyre D.R. Collagen type IX from human cartilage: a structural profile of intermolecular cross-linking sites. Biochem. J. 314:1996;327-332.
5. Eyre D.R., Matsui Y., Wu J.-J. Collagen polymorphisms of the intervertebral disc. Biochem. Soc. Trans. 30:2002;844-848.
6. Frymoyer J.W. Back pain and Sciatica. New Eng. J. Med. 318:1988;291-300.
7. Hasue M. Pain and the nerve root. An interdisciplinary approach. Spine. 18:1993;2053-2058.
8. Ichimura S., Wu J.-J., Eyre D.R. Two-dimensional peptide mapping of cross-linked type IX collagen in human cartilage. Arch. Biochem. Biophys. 378:2000;33-39.
9. Ikeda T., Mabuchi A., Fukuda A., et al. Association analysis of single nucleotide polymorphisms in cartilage-specific collagen genes with knee and hip osteoarthritis in the Japanese population. J. Bone Miner. Res. 17:2002;1290-1296.
10. Jensen M.C., Brant-Zawadzki M.N., Obuchowski N., Modic M.T., Malkasian D., Ross J.S. Magnetic resonance imaging of the lumbar spine in people without back pain. New Eng. J. Med. 331:1994;69-73.
11. Kimura T., Nakata K., Tsumaki N., et al. Progressive degeneration of articular cartilage and intervertebral discs. An experimental study in transgenic mice bearing a type IX collagen mutation. Int. Orthop. 20:1996;177-181.
12. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
13. Mendler M., Eich-Bender S.G., Vaughan L., Winterhalter K.H., Bruckner P. Cartilage contains mixed fibrils of collagen types II, IX, and XI. J. Cell. Biol. 108:1989;191-197.
14. Muragaki Y., Mariman E.C.M., van Beersum S.E.C., et al. A mutation in the gene encoding the alpha z chain of the fibril-associated collagen 1X, COL9A2, causes multiple epiphyseal dysplasia (EDM 2). Nat. Genet. 12:1996;103-105.
15. Nakata K., Ono K., Miyazaki J.-I., et al. Osteoarthritis associated with mild chondrodysplasia in transgenic mice expressing α1(IX) collagen chains with a central deletion. Proc. Natl. Acad. Sci. USA. 90:1993;2870-2874.
16. Newall J.F., Ayad S. Collagen IX isoforms in the intervertebral disc. Biochem. Soc. Trans. 23:1995;517S.
17. Nissim-Rafinia M., Kerem B. Splicing regulation as a potential genetic modifier. Trends Genet. 18:2002;123-127.
18. Ohnmeiss D.D., Vanharanta H., Ekholm J. Degree of disc disruption and lower extremity pain. Spine. 22:1997;1600-1605.
19. Olmarker K., Nordborg C., Larsson K., Rydevik B. Ultrastructural changes in spinal nerve roots induced by autologous nucleus pulposus. Spine. 21:1996;411-414.
20. Paassilta P., Lohiniva J., Goring H.H.H., et al. Identification of a novel common genetic risk factor for lumbar disc disease. JAMA. 285:2001;1843-1849.
21. Paassilta P., Pihlajamaa T., Annunen S., et al. Complete sequence of the 23-kilobase human COL9A3 gene. Detection of Gly-X-Y triplet deletions that represent neutral variants. J. Biol. Chem. 274:1999;22469-22475.
22. Pihlajamaa T., Vuoristo M.M., Annunen S., Perala M., Prockop D.J., Ala-Kokko L. Human COL9A1 and COL9A2 genes. Two genes of 90 and 15 kb code for similar polypeptides of the same collagen molecule. Matrix Biol. 17:1998;237-241.
23. Saal J.S. The role of inflammation in lumbar pain. Spine. 20:1995;1821-1827.
24. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning. A Laboratory Manual. second ed: 1989;Cold Spring Harbor Laboratory Press, New York.
25. Wrocklage C., Wassmann H., Paulus W. COL9A2 allelotypes in intervertebral disc disease. Biochem. Biophys. Res. Commun. 279:2000;398-400.
26. Wu J.-J., Eyre D.R. Evidence for the expression of a splicing variant of type IX collagen in articular cartilage. Trans. Orthop. Res. Soc. 22:1997;36.
27. Wu J.-J., Woods P.E., Eyre D.R. Identification of cross-linking sites in bovine cartilage type IX collagen reveals an antiparallel type II-type IX molecular relationship and type IX to type IX bonding. J. Biol. Chem. 267:1992;23007-23014.